- Featured News /
A new AI-enabled disease management tool in China aims to improve the lives of millions of patients with heart failure.
- Featured News /
Novartis data at 2019 ASH and SABCS underscore our evolving R&D approach in innovative platforms to reimagine medicine and help improve patient outcomes.
- Featured News /
We are partnering with the Friedrich Miescher Institute on more than 50 research projects to improve and extend people’s lives.
- Featured News /
It’s time to change the conversation. Patient inspired and community led, Sound Up aims to empower people affected by lung cancer in raising the volume to vocally self-advocate.
- Featured News /
Despite advancements in care, prostate cancer is one of the most frequently diagnosed cancers around the world. This Movember, we’re focused on raising awareness of prostate cancer.
- Featured News /
Novartis is working with partners around the world to help eliminate preventable visual impairment and blindness by reimagining access to eye care.
- Media Release /New data from the Phase 3 ASCLEPIOS I/II trials and ALITHIOS open-label extension show that after four years nearly 8 out of 10 of people with relapsing multiple sclerosis (RMS) treated continuously…
- Key Release /Ad hoc announcement pursuant to Art. 53 LR Q4 sales grew +6% (cc1, +4% USD) and core operating income grew +12% (cc, +9% USD) IM sales grew +7% (cc, +5% USD) and core operating income +15% (cc, +12…
- Key Release /Annonce événementielle selon l’art. 53 RC Chiffre d’affaires net du 4e trimestre en hausse de +6% (tcc1, +4% USD) et résultat opérationnel core croissant de +12% (tcc1, +9% USD) Innovative…
Pagination
- ‹ Previous page
- 1
- …
- 96
- 97
- 98
- 99
- 100
- 101
- 102
- …
- 267
- › Next page